Literature DB >> 19942056

MRI of brain disease in veterinary patients part 2: Acquired brain disorders.

Silke Hecht1, William H Adams.   

Abstract

Magnetic resonance imaging (MRI) has revolutionized brain imaging in veterinary medicine, making possible improved characterization of intracranial pathologic processes. This article focuses on MRI features of acquired brain disorders, including infectious inflammatory, noninfectious inflammatory, cerebrovascular, metabolic, nutritional, toxic, degenerative, traumatic, and neoplastic causes. Congenital intracranial disorders are covered in a companion article.

Entities:  

Mesh：

Year:  2010        PMID： 19942056     DOI： 10.1016/j.cvsm.2009.09.006

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN： 0195-5616            Impact factor:   2.093


  3 in total

1.  Agreement of Magnetic Resonance Imaging With Computed Tomography in the Assessment for Acute Skull Fractures in a Canine and Feline Cadaver Model.

Authors:  Silke Hecht; Kimberly M Anderson; Aude Castel; John F Griffin; Adrien-Maxence Hespel; Nathan Nelson; Xiaocun Sun
Journal:  Front Vet Sci       Date:  2021-04-22

2.  International Veterinary Epilepsy Task Force recommendations for a veterinary epilepsy-specific MRI protocol.

Authors:  Clare Rusbridge; Sam Long; Jelena Jovanovik; Marjorie Milne; Mette Berendt; Sofie F M Bhatti; Luisa De Risio; Robyn G Farqhuar; Andrea Fischer; Kaspar Matiasek; Karen Muñana; Edward E Patterson; Akos Pakozdy; Jacques Penderis; Simon Platt; Michael Podell; Heidrun Potschka; Veronika M Stein; Andrea Tipold; Holger A Volk
Journal:  BMC Vet Res       Date:  2015-08-28       Impact factor: 2.741

3.  Detection of blood-brain barrier dysfunction using advanced imaging methods to predict seizures in dogs with meningoencephalitis of unknown origin.

Authors:  Erez Hanael; Shelly Baruch; Orit Chai; Zohar Nir; Kira Rapoport; Marco Ruggeri; Itzhak Eizenberg; Dana Peery; Alon Friedman; Merav H Shamir
Journal:  J Vet Intern Med       Date:  2022-03-14       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.